The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Ophthalmic Drug Delivery System Market Research Report 2024
Synopsis
Due to the COVID-19 pandemic, the global Ophthalmic Drug Delivery System market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Ophthalmic Drug Delivery System market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Ophthalmic Drug Delivery System landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Implantable Ophthalmic Drug Delivery Systems accounting for % of the Ophthalmic Drug Delivery System global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Ophthalmic Drug Delivery System include Aero Pump GmbH, AptarGroup, Bausch Health, Becton Dickinson & Company, EyePoint Pharmaceuticals, Inc., Gaplast GmbH, Gerresheimer, Nemera and Nipro Corporation, etc. In terms of revenue, the global 3 largest players have a % market share of Ophthalmic Drug Delivery System in 2021.
This report focuses on Ophthalmic Drug Delivery System volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Ophthalmic Drug Delivery System market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Ophthalmic Drug Delivery System Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Implantable Ophthalmic Drug Delivery Systems
Particulate Ophthalmic Drug Delivery Systems
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Aero Pump GmbH
AptarGroup
Bausch Health
Becton Dickinson & Company
EyePoint Pharmaceuticals, Inc.
Gaplast GmbH
Gerresheimer
Nemera
Nipro Corporation
Ocular Therapeutix
Owen Mumford
Silgan Holdings Inc.
Terumo Corporation
West Pharmaceutical Services, Inc.
Kedalion Therapeutics
Re-Vana Therapeutics
Mati Therapeutics, Inc.,
Biocorp Production
Ocumedic, Inc.
Graybug Vision
Taiwan Liposome
Santen Pharmaceutical
Envisia Therapeutics
Clearside Biomedical
Due to the COVID-19 pandemic, the global Ophthalmic Drug Delivery System market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Ophthalmic Drug Delivery System market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Ophthalmic Drug Delivery System landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Implantable Ophthalmic Drug Delivery Systems accounting for % of the Ophthalmic Drug Delivery System global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Ophthalmic Drug Delivery System include Aero Pump GmbH, AptarGroup, Bausch Health, Becton Dickinson & Company, EyePoint Pharmaceuticals, Inc., Gaplast GmbH, Gerresheimer, Nemera and Nipro Corporation, etc. In terms of revenue, the global 3 largest players have a % market share of Ophthalmic Drug Delivery System in 2021.
This report focuses on Ophthalmic Drug Delivery System volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Ophthalmic Drug Delivery System market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Ophthalmic Drug Delivery System Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Implantable Ophthalmic Drug Delivery Systems
Particulate Ophthalmic Drug Delivery Systems
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Aero Pump GmbH
AptarGroup
Bausch Health
Becton Dickinson & Company
EyePoint Pharmaceuticals, Inc.
Gaplast GmbH
Gerresheimer
Nemera
Nipro Corporation
Ocular Therapeutix
Owen Mumford
Silgan Holdings Inc.
Terumo Corporation
West Pharmaceutical Services, Inc.
Kedalion Therapeutics
Re-Vana Therapeutics
Mati Therapeutics, Inc.,
Biocorp Production
Ocumedic, Inc.
Graybug Vision
Taiwan Liposome
Santen Pharmaceutical
Envisia Therapeutics
Clearside Biomedical
Index1 Ophthalmic Drug Delivery System Market Overview
1.1 Product Overview and Scope of Ophthalmic Drug Delivery System
1.2 Ophthalmic Drug Delivery System Segment by Type
1.2.1 Global Ophthalmic Drug Delivery System Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Implantable Ophthalmic Drug Delivery Systems
1.2.3 Particulate Ophthalmic Drug Delivery Systems
1.2.4 Others
1.3 Ophthalmic Drug Delivery System Segment by Application
1.3.1 Global Ophthalmic Drug Delivery System Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Global Ophthalmic Drug Delivery System Market Size Estimates and Forecasts
1.4.1 Global Ophthalmic Drug Delivery System Revenue 2017-2028
1.4.2 Global Ophthalmic Drug Delivery System Sales 2017-2028
1.4.3 Ophthalmic Drug Delivery System Market Size by Region: 2017 Versus 2021 Versus 2028
2 Ophthalmic Drug Delivery System Market Competition by Manufacturers
2.1 Global Ophthalmic Drug Delivery System Sales Market Share by Manufacturers (2017-2022)
2.2 Global Ophthalmic Drug Delivery System Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Ophthalmic Drug Delivery System Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Ophthalmic Drug Delivery System Manufacturing Sites, Area Served, Product Type
2.5 Ophthalmic Drug Delivery System Market Competitive Situation and Trends
2.5.1 Ophthalmic Drug Delivery System Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Ophthalmic Drug Delivery System Players Market Share by Revenue
2.5.3 Global Ophthalmic Drug Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ophthalmic Drug Delivery System Retrospective Market Scenario by Region
3.1 Global Ophthalmic Drug Delivery System Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Ophthalmic Drug Delivery System Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Ophthalmic Drug Delivery System Market Facts & Figures by Country
3.3.1 North America Ophthalmic Drug Delivery System Sales by Country
3.3.2 North America Ophthalmic Drug Delivery System Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Ophthalmic Drug Delivery System Market Facts & Figures by Country
3.4.1 Europe Ophthalmic Drug Delivery System Sales by Country
3.4.2 Europe Ophthalmic Drug Delivery System Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Ophthalmic Drug Delivery System Market Facts & Figures by Region
3.5.1 Asia Pacific Ophthalmic Drug Delivery System Sales by Region
3.5.2 Asia Pacific Ophthalmic Drug Delivery System Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Ophthalmic Drug Delivery System Market Facts & Figures by Country
3.6.1 Latin America Ophthalmic Drug Delivery System Sales by Country
3.6.2 Latin America Ophthalmic Drug Delivery System Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Ophthalmic Drug Delivery System Market Facts & Figures by Country
3.7.1 Middle East and Africa Ophthalmic Drug Delivery System Sales by Country
3.7.2 Middle East and Africa Ophthalmic Drug Delivery System Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Ophthalmic Drug Delivery System Historic Market Analysis by Type
4.1 Global Ophthalmic Drug Delivery System Sales Market Share by Type (2017-2022)
4.2 Global Ophthalmic Drug Delivery System Revenue Market Share by Type (2017-2022)
4.3 Global Ophthalmic Drug Delivery System Price by Type (2017-2022)
5 Global Ophthalmic Drug Delivery System Historic Market Analysis by Application
5.1 Global Ophthalmic Drug Delivery System Sales Market Share by Application (2017-2022)
5.2 Global Ophthalmic Drug Delivery System Revenue Market Share by Application (2017-2022)
5.3 Global Ophthalmic Drug Delivery System Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Aero Pump GmbH
6.1.1 Aero Pump GmbH Corporation Information
6.1.2 Aero Pump GmbH Description and Business Overview
6.1.3 Aero Pump GmbH Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Aero Pump GmbH Ophthalmic Drug Delivery System Product Portfolio
6.1.5 Aero Pump GmbH Recent Developments/Updates
6.2 AptarGroup
6.2.1 AptarGroup Corporation Information
6.2.2 AptarGroup Description and Business Overview
6.2.3 AptarGroup Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.2.4 AptarGroup Ophthalmic Drug Delivery System Product Portfolio
6.2.5 AptarGroup Recent Developments/Updates
6.3 Bausch Health
6.3.1 Bausch Health Corporation Information
6.3.2 Bausch Health Description and Business Overview
6.3.3 Bausch Health Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Bausch Health Ophthalmic Drug Delivery System Product Portfolio
6.3.5 Bausch Health Recent Developments/Updates
6.4 Becton Dickinson & Company
6.4.1 Becton Dickinson & Company Corporation Information
6.4.2 Becton Dickinson & Company Description and Business Overview
6.4.3 Becton Dickinson & Company Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Becton Dickinson & Company Ophthalmic Drug Delivery System Product Portfolio
6.4.5 Becton Dickinson & Company Recent Developments/Updates
6.5 EyePoint Pharmaceuticals, Inc.
6.5.1 EyePoint Pharmaceuticals, Inc. Corporation Information
6.5.2 EyePoint Pharmaceuticals, Inc. Description and Business Overview
6.5.3 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.5.4 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Product Portfolio
6.5.5 EyePoint Pharmaceuticals, Inc. Recent Developments/Updates
6.6 Gaplast GmbH
6.6.1 Gaplast GmbH Corporation Information
6.6.2 Gaplast GmbH Description and Business Overview
6.6.3 Gaplast GmbH Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Gaplast GmbH Ophthalmic Drug Delivery System Product Portfolio
6.6.5 Gaplast GmbH Recent Developments/Updates
6.7 Gerresheimer
6.6.1 Gerresheimer Corporation Information
6.6.2 Gerresheimer Description and Business Overview
6.6.3 Gerresheimer Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Gerresheimer Ophthalmic Drug Delivery System Product Portfolio
6.7.5 Gerresheimer Recent Developments/Updates
6.8 Nemera
6.8.1 Nemera Corporation Information
6.8.2 Nemera Description and Business Overview
6.8.3 Nemera Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Nemera Ophthalmic Drug Delivery System Product Portfolio
6.8.5 Nemera Recent Developments/Updates
6.9 Nipro Corporation
6.9.1 Nipro Corporation Corporation Information
6.9.2 Nipro Corporation Description and Business Overview
6.9.3 Nipro Corporation Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Nipro Corporation Ophthalmic Drug Delivery System Product Portfolio
6.9.5 Nipro Corporation Recent Developments/Updates
6.10 Ocular Therapeutix
6.10.1 Ocular Therapeutix Corporation Information
6.10.2 Ocular Therapeutix Description and Business Overview
6.10.3 Ocular Therapeutix Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Ocular Therapeutix Ophthalmic Drug Delivery System Product Portfolio
6.10.5 Ocular Therapeutix Recent Developments/Updates
6.11 Owen Mumford
6.11.1 Owen Mumford Corporation Information
6.11.2 Owen Mumford Ophthalmic Drug Delivery System Description and Business Overview
6.11.3 Owen Mumford Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Owen Mumford Ophthalmic Drug Delivery System Product Portfolio
6.11.5 Owen Mumford Recent Developments/Updates
6.12 Silgan Holdings Inc.
6.12.1 Silgan Holdings Inc. Corporation Information
6.12.2 Silgan Holdings Inc. Ophthalmic Drug Delivery System Description and Business Overview
6.12.3 Silgan Holdings Inc. Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Silgan Holdings Inc. Ophthalmic Drug Delivery System Product Portfolio
6.12.5 Silgan Holdings Inc. Recent Developments/Updates
6.13 Terumo Corporation
6.13.1 Terumo Corporation Corporation Information
6.13.2 Terumo Corporation Ophthalmic Drug Delivery System Description and Business Overview
6.13.3 Terumo Corporation Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Terumo Corporation Ophthalmic Drug Delivery System Product Portfolio
6.13.5 Terumo Corporation Recent Developments/Updates
6.14 West Pharmaceutical Services, Inc.
6.14.1 West Pharmaceutical Services, Inc. Corporation Information
6.14.2 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Description and Business Overview
6.14.3 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.14.4 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Product Portfolio
6.14.5 West Pharmaceutical Services, Inc. Recent Developments/Updates
6.15 Kedalion Therapeutics
6.15.1 Kedalion Therapeutics Corporation Information
6.15.2 Kedalion Therapeutics Ophthalmic Drug Delivery System Description and Business Overview
6.15.3 Kedalion Therapeutics Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Kedalion Therapeutics Ophthalmic Drug Delivery System Product Portfolio
6.15.5 Kedalion Therapeutics Recent Developments/Updates
6.16 Re-Vana Therapeutics
6.16.1 Re-Vana Therapeutics Corporation Information
6.16.2 Re-Vana Therapeutics Ophthalmic Drug Delivery System Description and Business Overview
6.16.3 Re-Vana Therapeutics Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Re-Vana Therapeutics Ophthalmic Drug Delivery System Product Portfolio
6.16.5 Re-Vana Therapeutics Recent Developments/Updates
6.17 Mati Therapeutics, Inc.,
6.17.1 Mati Therapeutics, Inc., Corporation Information
6.17.2 Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Description and Business Overview
6.17.3 Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Product Portfolio
6.17.5 Mati Therapeutics, Inc., Recent Developments/Updates
6.18 Biocorp Production
6.18.1 Biocorp Production Corporation Information
6.18.2 Biocorp Production Ophthalmic Drug Delivery System Description and Business Overview
6.18.3 Biocorp Production Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Biocorp Production Ophthalmic Drug Delivery System Product Portfolio
6.18.5 Biocorp Production Recent Developments/Updates
6.19 Ocumedic, Inc.
6.19.1 Ocumedic, Inc. Corporation Information
6.19.2 Ocumedic, Inc. Ophthalmic Drug Delivery System Description and Business Overview
6.19.3 Ocumedic, Inc. Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Ocumedic, Inc. Ophthalmic Drug Delivery System Product Portfolio
6.19.5 Ocumedic, Inc. Recent Developments/Updates
6.20 Graybug Vision
6.20.1 Graybug Vision Corporation Information
6.20.2 Graybug Vision Ophthalmic Drug Delivery System Description and Business Overview
6.20.3 Graybug Vision Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Graybug Vision Ophthalmic Drug Delivery System Product Portfolio
6.20.5 Graybug Vision Recent Developments/Updates
6.21 Taiwan Liposome
6.21.1 Taiwan Liposome Corporation Information
6.21.2 Taiwan Liposome Ophthalmic Drug Delivery System Description and Business Overview
6.21.3 Taiwan Liposome Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.21.4 Taiwan Liposome Ophthalmic Drug Delivery System Product Portfolio
6.21.5 Taiwan Liposome Recent Developments/Updates
6.22 Santen Pharmaceutical
6.22.1 Santen Pharmaceutical Corporation Information
6.22.2 Santen Pharmaceutical Ophthalmic Drug Delivery System Description and Business Overview
6.22.3 Santen Pharmaceutical Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.22.4 Santen Pharmaceutical Ophthalmic Drug Delivery System Product Portfolio
6.22.5 Santen Pharmaceutical Recent Developments/Updates
6.23 Envisia Therapeutics
6.23.1 Envisia Therapeutics Corporation Information
6.23.2 Envisia Therapeutics Ophthalmic Drug Delivery System Description and Business Overview
6.23.3 Envisia Therapeutics Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.23.4 Envisia Therapeutics Ophthalmic Drug Delivery System Product Portfolio
6.23.5 Envisia Therapeutics Recent Developments/Updates
6.24 Clearside Biomedical
6.24.1 Clearside Biomedical Corporation Information
6.24.2 Clearside Biomedical Ophthalmic Drug Delivery System Description and Business Overview
6.24.3 Clearside Biomedical Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.24.4 Clearside Biomedical Ophthalmic Drug Delivery System Product Portfolio
6.24.5 Clearside Biomedical Recent Developments/Updates
7 Ophthalmic Drug Delivery System Manufacturing Cost Analysis
7.1 Ophthalmic Drug Delivery System Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Ophthalmic Drug Delivery System
7.4 Ophthalmic Drug Delivery System Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Ophthalmic Drug Delivery System Distributors List
8.3 Ophthalmic Drug Delivery System Customers
9 Ophthalmic Drug Delivery System Market Dynamics
9.1 Ophthalmic Drug Delivery System Industry Trends
9.2 Ophthalmic Drug Delivery System Market Drivers
9.3 Ophthalmic Drug Delivery System Market Challenges
9.4 Ophthalmic Drug Delivery System Market Restraints
10 Global Market Forecast
10.1 Ophthalmic Drug Delivery System Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Ophthalmic Drug Delivery System by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Ophthalmic Drug Delivery System by Type (2023-2028)
10.2 Ophthalmic Drug Delivery System Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Ophthalmic Drug Delivery System by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Ophthalmic Drug Delivery System by Application (2023-2028)
10.3 Ophthalmic Drug Delivery System Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Ophthalmic Drug Delivery System by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Ophthalmic Drug Delivery System by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Ophthalmic Drug Delivery System Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Ophthalmic Drug Delivery System Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Ophthalmic Drug Delivery System Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Ophthalmic Drug Delivery System Market Competitive Situation by Manufacturers in 2021
Table 5. Global Ophthalmic Drug Delivery System Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Ophthalmic Drug Delivery System Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Ophthalmic Drug Delivery System Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Ophthalmic Drug Delivery System Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Ophthalmic Drug Delivery System Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Ophthalmic Drug Delivery System Manufacturing Sites and Area Served
Table 11. Manufacturers Ophthalmic Drug Delivery System Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Ophthalmic Drug Delivery System by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ophthalmic Drug Delivery System as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Ophthalmic Drug Delivery System Sales by Region (2017-2022) & (K Units)
Table 16. Global Ophthalmic Drug Delivery System Sales Market Share by Region (2017-2022)
Table 17. Global Ophthalmic Drug Delivery System Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Ophthalmic Drug Delivery System Revenue Market Share by Region (2017-2022)
Table 19. North America Ophthalmic Drug Delivery System Sales by Country (2017-2022) & (K Units)
Table 20. North America Ophthalmic Drug Delivery System Sales Market Share by Country (2017-2022)
Table 21. North America Ophthalmic Drug Delivery System Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Ophthalmic Drug Delivery System Revenue Market Share by Country (2017-2022)
Table 23. Europe Ophthalmic Drug Delivery System Sales by Country (2017-2022) & (K Units)
Table 24. Europe Ophthalmic Drug Delivery System Sales Market Share by Country (2017-2022)
Table 25. Europe Ophthalmic Drug Delivery System Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Ophthalmic Drug Delivery System Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Ophthalmic Drug Delivery System Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Ophthalmic Drug Delivery System Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Ophthalmic Drug Delivery System Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Ophthalmic Drug Delivery System Revenue Market Share by Region (2017-2022)
Table 31. Latin America Ophthalmic Drug Delivery System Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Ophthalmic Drug Delivery System Sales Market Share by Country (2017-2022)
Table 33. Latin America Ophthalmic Drug Delivery System Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Ophthalmic Drug Delivery System Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Ophthalmic Drug Delivery System Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Ophthalmic Drug Delivery System Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Ophthalmic Drug Delivery System Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Ophthalmic Drug Delivery System Revenue Market Share by Country (2017-2022)
Table 39. Global Ophthalmic Drug Delivery System Sales by Type (2017-2022) & (K Units)
Table 40. Global Ophthalmic Drug Delivery System Sales Market Share by Type (2017-2022)
Table 41. Global Ophthalmic Drug Delivery System Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Ophthalmic Drug Delivery System Revenue Share by Type (2017-2022)
Table 43. Global Ophthalmic Drug Delivery System Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Ophthalmic Drug Delivery System Sales (K Units) by Application (2017-2022)
Table 45. Global Ophthalmic Drug Delivery System Sales Market Share by Application (2017-2022)
Table 46. Global Ophthalmic Drug Delivery System Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Ophthalmic Drug Delivery System Revenue Share by Application (2017-2022)
Table 48. Global Ophthalmic Drug Delivery System Price by Application (2017-2022) & (US$/Unit)
Table 49. Aero Pump GmbH Corporation Information
Table 50. Aero Pump GmbH Description and Business Overview
Table 51. Aero Pump GmbH Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Aero Pump GmbH Ophthalmic Drug Delivery System Product
Table 53. Aero Pump GmbH Recent Developments/Updates
Table 54. AptarGroup Corporation Information
Table 55. AptarGroup Description and Business Overview
Table 56. AptarGroup Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. AptarGroup Ophthalmic Drug Delivery System Product
Table 58. AptarGroup Recent Developments/Updates
Table 59. Bausch Health Corporation Information
Table 60. Bausch Health Description and Business Overview
Table 61. Bausch Health Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Bausch Health Ophthalmic Drug Delivery System Product
Table 63. Bausch Health Recent Developments/Updates
Table 64. Becton Dickinson & Company Corporation Information
Table 65. Becton Dickinson & Company Description and Business Overview
Table 66. Becton Dickinson & Company Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Becton Dickinson & Company Ophthalmic Drug Delivery System Product
Table 68. Becton Dickinson & Company Recent Developments/Updates
Table 69. EyePoint Pharmaceuticals, Inc. Corporation Information
Table 70. EyePoint Pharmaceuticals, Inc. Description and Business Overview
Table 71. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Product
Table 73. EyePoint Pharmaceuticals, Inc. Recent Developments/Updates
Table 74. Gaplast GmbH Corporation Information
Table 75. Gaplast GmbH Description and Business Overview
Table 76. Gaplast GmbH Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Gaplast GmbH Ophthalmic Drug Delivery System Product
Table 78. Gaplast GmbH Recent Developments/Updates
Table 79. Gerresheimer Corporation Information
Table 80. Gerresheimer Description and Business Overview
Table 81. Gerresheimer Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Gerresheimer Ophthalmic Drug Delivery System Product
Table 83. Gerresheimer Recent Developments/Updates
Table 84. Nemera Corporation Information
Table 85. Nemera Description and Business Overview
Table 86. Nemera Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Nemera Ophthalmic Drug Delivery System Product
Table 88. Nemera Recent Developments/Updates
Table 89. Nipro Corporation Corporation Information
Table 90. Nipro Corporation Description and Business Overview
Table 91. Nipro Corporation Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Nipro Corporation Ophthalmic Drug Delivery System Product
Table 93. Nipro Corporation Recent Developments/Updates
Table 94. Ocular Therapeutix Corporation Information
Table 95. Ocular Therapeutix Description and Business Overview
Table 96. Ocular Therapeutix Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Ocular Therapeutix Ophthalmic Drug Delivery System Product
Table 98. Ocular Therapeutix Recent Developments/Updates
Table 99. Owen Mumford Corporation Information
Table 100. Owen Mumford Description and Business Overview
Table 101. Owen Mumford Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Owen Mumford Ophthalmic Drug Delivery System Product
Table 103. Owen Mumford Recent Developments/Updates
Table 104. Silgan Holdings Inc. Corporation Information
Table 105. Silgan Holdings Inc. Description and Business Overview
Table 106. Silgan Holdings Inc. Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. Silgan Holdings Inc. Ophthalmic Drug Delivery System Product
Table 108. Silgan Holdings Inc. Recent Developments/Updates
Table 109. Terumo Corporation Corporation Information
Table 110. Terumo Corporation Description and Business Overview
Table 111. Terumo Corporation Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Terumo Corporation Ophthalmic Drug Delivery System Product
Table 113. Terumo Corporation Recent Developments/Updates
Table 114. West Pharmaceutical Services, Inc. Corporation Information
Table 115. West Pharmaceutical Services, Inc. Description and Business Overview
Table 116. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Product
Table 118. West Pharmaceutical Services, Inc. Recent Developments/Updates
Table 119. Kedalion Therapeutics Corporation Information
Table 120. Kedalion Therapeutics Description and Business Overview
Table 121. Kedalion Therapeutics Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Kedalion Therapeutics Ophthalmic Drug Delivery System Product
Table 123. Kedalion Therapeutics Recent Developments/Updates
Table 124. Re-Vana Therapeutics Corporation Information
Table 125. Re-Vana Therapeutics Description and Business Overview
Table 126. Re-Vana Therapeutics Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. Re-Vana Therapeutics Ophthalmic Drug Delivery System Product
Table 128. Re-Vana Therapeutics Recent Developments/Updates
Table 129. Mati Therapeutics, Inc., Corporation Information
Table 130. Mati Therapeutics, Inc., Description and Business Overview
Table 131. Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Product
Table 133. Mati Therapeutics, Inc., Recent Developments/Updates
Table 134. Biocorp Production Corporation Information
Table 135. Biocorp Production Description and Business Overview
Table 136. Biocorp Production Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 137. Biocorp Production Ophthalmic Drug Delivery System Product
Table 138. Biocorp Production Recent Developments/Updates
Table 139. Ocumedic, Inc. Corporation Information
Table 140. Ocumedic, Inc. Description and Business Overview
Table 141. Ocumedic, Inc. Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 142. Ocumedic, Inc. Ophthalmic Drug Delivery System Product
Table 143. Ocumedic, Inc. Recent Developments/Updates
Table 144. Graybug Vision Corporation Information
Table 145. Graybug Vision Description and Business Overview
Table 146. Graybug Vision Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 147. Graybug Vision Ophthalmic Drug Delivery System Product
Table 148. Graybug Vision Recent Developments/Updates
Table 149. Taiwan Liposome Corporation Information
Table 150. Taiwan Liposome Description and Business Overview
Table 151. Taiwan Liposome Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 152. Taiwan Liposome Ophthalmic Drug Delivery System Product
Table 153. Taiwan Liposome Recent Developments/Updates
Table 154. Santen Pharmaceutical Corporation Information
Table 155. Santen Pharmaceutical Description and Business Overview
Table 156. Santen Pharmaceutical Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 157. Santen Pharmaceutical Ophthalmic Drug Delivery System Product
Table 158. Santen Pharmaceutical Recent Developments/Updates
Table 159. Envisia Therapeutics Corporation Information
Table 160. Envisia Therapeutics Description and Business Overview
Table 161. Envisia Therapeutics Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 162. Envisia Therapeutics Ophthalmic Drug Delivery System Product
Table 163. Envisia Therapeutics Recent Developments/Updates
Table 164. Clearside Biomedical Corporation Information
Table 165. Clearside Biomedical Description and Business Overview
Table 166. Clearside Biomedical Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 167. Clearside Biomedical Ophthalmic Drug Delivery System Product
Table 168. Clearside Biomedical Recent Developments/Updates
Table 169. Production Base and Market Concentration Rate of Raw Material
Table 170. Key Suppliers of Raw Materials
Table 171. Ophthalmic Drug Delivery System Distributors List
Table 172. Ophthalmic Drug Delivery System Customers List
Table 173. Ophthalmic Drug Delivery System Market Trends
Table 174. Ophthalmic Drug Delivery System Market Drivers
Table 175. Ophthalmic Drug Delivery System Market Challenges
Table 176. Ophthalmic Drug Delivery System Market Restraints
Table 177. Global Ophthalmic Drug Delivery System Sales Forecast by Type (2023-2028) & (K Units)
Table 178. Global Ophthalmic Drug Delivery System Sales Market Share Forecast by Type (2023-2028)
Table 179. Global Ophthalmic Drug Delivery System Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 180. Global Ophthalmic Drug Delivery System Revenue Market Share Forecast by Type (2023-2028)
Table 181. Global Ophthalmic Drug Delivery System Sales Forecast by Application (2023-2028) & (K Units)
Table 182. Global Ophthalmic Drug Delivery System Sales Market Share Forecast by Application (2023-2028)
Table 183. Global Ophthalmic Drug Delivery System Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 184. Global Ophthalmic Drug Delivery System Revenue Market Share Forecast by Application (2023-2028)
Table 185. Global Ophthalmic Drug Delivery System Sales Forecast by Region (2023-2028) & (K Units)
Table 186. Global Ophthalmic Drug Delivery System Sales Market Share Forecast by Region (2023-2028)
Table 187. Global Ophthalmic Drug Delivery System Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 188. Global Ophthalmic Drug Delivery System Revenue Market Share Forecast by Region (2023-2028)
Table 189. Research Programs/Design for This Report
Table 190. Key Data Information from Secondary Sources
Table 191. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Ophthalmic Drug Delivery System
Figure 2. Global Ophthalmic Drug Delivery System Market Share by Type in 2021 & 2028
Figure 3. Implantable Ophthalmic Drug Delivery Systems Product Picture
Figure 4. Particulate Ophthalmic Drug Delivery Systems Product Picture
Figure 5. Others Product Picture
Figure 6. Global Ophthalmic Drug Delivery System Market Share by Application in 2021 & 2028
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Ambulatory Surgical Centers
Figure 10. Others
Figure 11. Global Ophthalmic Drug Delivery System Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Ophthalmic Drug Delivery System Market Size (2017-2028) & (US$ Million)
Figure 13. Global Ophthalmic Drug Delivery System Sales (2017-2028) & (K Units)
Figure 14. Ophthalmic Drug Delivery System Sales Share by Manufacturers in 2021
Figure 15. Global Ophthalmic Drug Delivery System Revenue Share by Manufacturers in 2021
Figure 16. The Global 5 and 10 Largest Ophthalmic Drug Delivery System Players: Market Share by Revenue in 2021
Figure 17. Ophthalmic Drug Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Ophthalmic Drug Delivery System Sales Market Share by Region (2017-2022)
Figure 19. Global Ophthalmic Drug Delivery System Sales Market Share by Region in 2021
Figure 20. Global Ophthalmic Drug Delivery System Revenue Market Share by Region (2017-2022)
Figure 21. Global Ophthalmic Drug Delivery System Revenue Market Share by Region in 2021
Figure 22. United States Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Canada Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Germany Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. France Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. U.K. Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Italy Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Russia Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. China Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Japan Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. South Korea Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. India Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Australia Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. China Taiwan Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Indonesia Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Thailand Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Malaysia Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Mexico Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Brazil Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Argentina Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Turkey Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Saudi Arabia Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. UAE Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Sales Market Share of Ophthalmic Drug Delivery System by Type (2017-2022)
Figure 45. Manufacturing Cost Structure of Ophthalmic Drug Delivery System
Figure 46. Manufacturing Process Analysis of Ophthalmic Drug Delivery System
Figure 47. Ophthalmic Drug Delivery System Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
